Cryo-Cell International I...

6.40
0.03 (0.47%)
At close: Apr 01, 2025, 3:57 PM
6.60
3.12%
Pre-market: Apr 02, 2025, 07:00 AM EDT

Cryo-Cell International Statistics

Share Statistics

Cryo-Cell International has 8.08M shares outstanding. The number of shares has increased by -0.28% in one year.

Shares Outstanding 8.08M
Shares Change (YoY) -0.28%
Shares Change (QoQ) 0.25%
Owned by Institutions (%) 12.79%
Shares Floating 4.43M
Failed to Deliver (FTD) Shares 2
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 15.67K, so 0.19% of the outstanding shares have been sold short.

Short Interest 15.67K
Short % of Shares Out 0.19%
Short % of Float 0.41%
Short Ratio (days to cover) 1.13

Valuation Ratios

The PE ratio is 175.31 and the forward PE ratio is 62.33. Cryo-Cell International's PEG ratio is -1.12.

PE Ratio 175.31
Forward PE 62.33
PS Ratio 2.2
Forward PS 1.6
PB Ratio -5.33
P/FCF Ratio 19.54
PEG Ratio -1.12
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Cryo-Cell International.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.58, with a Debt / Equity ratio of -0.34.

Current Ratio 0.58
Quick Ratio 0.55
Debt / Equity -0.34
Total Debt / Capitalization 0.06
Interest Coverage 1.87

Financial Efficiency

Return on equity (ROE) is null% and return on capital (ROIC) is null%.

Return on Equity null
Return on Assets null
Return on Capital null
Revenue Per Employee $390,074.46
Profits Per Employee $4,903.6
Employee Count 82
Asset Turnover 0.49
Inventory Turnover 12.08

Taxes

Income Tax 2.4M
Effective Tax Rate 0.86

Stock Price Statistics

The stock price has increased by -14.55% in the last 52 weeks. The beta is 0.64, so Cryo-Cell International's price volatility has been higher than the market average.

Beta 0.64
52-Week Price Change -14.55%
50-Day Moving Average 7.22
200-Day Moving Average 7.28
Relative Strength Index (RSI) 42.96
Average Volume (20 Days) 14.98K

Income Statement

In the last 12 months, Cryo-Cell International had revenue of 31.99M and earned 402.1K in profits. Earnings per share was 0.64.

Revenue 31.99M
Gross Profit 24.04M
Operating Income 3.48M
Net Income 402.1K
EBITDA 1.42M
EBIT 939.44K
Earnings Per Share (EPS) 0.64
Full Income Statement

Balance Sheet

The company has 560.96K in cash and 4.45M in debt, giving a net cash position of -3.89M.

Cash & Cash Equivalents 560.96K
Total Debt 4.45M
Net Cash -3.89M
Retained Earnings -32.78M
Total Assets 64.68M
Working Capital -9.04M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.01M and capital expenditures -2.4M, giving a free cash flow of 3.61M.

Operating Cash Flow 6.01M
Capital Expenditures -2.4M
Free Cash Flow 3.61M
FCF Per Share 0.44
Full Cash Flow Statement

Margins

Gross margin is 0.75, with operating and profit margins of 0.11 and 0.01.

Gross Margin 0.75
Operating Margin 0.11
Pretax Margin 0.09
Profit Margin 0.01
EBITDA Margin 4.45
EBIT Margin 10.88
FCF Margin 11.28

Dividends & Yields

CCEL does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CCEL is $8.5, which is 32.8% higher than the current price. The consensus rating is "Buy".

Price Target $8.5
Price Target Difference 32.8%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Scores

Altman Z-Score 0.16
Piotroski F-Score 9